Complement Levels |
|
|
Clinical Trial: Effect of TAK-475 or Placebo on Blood Cholesterol Levels in Subjects That Are Co-Administered Atorvastatin
This study is currently recruiting patients.
Verified by Takeda Global Research & Development Center, Inc. August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Hyperlipidemia Hypercholesterolemia | Drug: TAK-475 | Phase III |
MedlinePlus related topics: Cholesterol; Metabolic Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: A Double-Blind, Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-475 50 Mg, 100 Mg, or Placebo When Co-Administered with Atorvastatin (10 Mg to 40 Mg) in Subjects with Primary Hypercholesterolemia
Expected Total Enrollment: 420
Study start: August 2005; Expected completion: October 2007
Last follow-up: October 2006; Data entry closure: December 2006
Eligibility
Inclusion Criteria:
- Male or female who is at least 18 years of age.
- The subject must have a normal physical examination and normal laboratory results at screening.
- The subject must have been taking the same daily dose of atorvastatin for at least 4 weeks prior to starting the study.
- The subject must have 2 blood draws at least one week apart whose results demonstrate hypercholesterolemia.
Exclusion Criteria:
- Subject with diabetes whose HbA1c > 8%.
- Subject has elevated ALT, AST, CPK, and serum creatinine above the pre-specified criteria.
- Subject has blood pressure over 160/100. Taking stable medication for high blood pressure is allowed.
- Subject had heart problems in the prior 6 months
Location and Contact Information
Alabama
Birmingham, Alabama, United States; Recruiting
Northport, Alabama, United States; Recruiting
Arizona
Sierra Vista, Arizona, United States; Recruiting
Tucson, Arizona, United States; Recruiting
Arkansas
Jonesboro, Arkansas, United States; Recruiting
Searcy, Arkansas, United States; Recruiting
California
Anaheim, California, United States; Recruiting
Carmichael, California, United States; Recruiting
Escondido, California, United States; Recruiting
Pismo Beach, California, United States; Recruiting
Santa Rosa, California, United States; Recruiting
Chula Vista, California, United States; Recruiting
Colorado
Golden, Colorado, United States; Recruiting
Connecticut
Waterbury, Connecticut, United States; Recruiting
Florida
Clearwater, Florida, United States; Recruiting
Daytona Beach, Florida, United States; Recruiting
Hollywood, Florida, United States; Recruiting
Jacksonville, Florida, United States; Recruiting
Jupiter, Florida, United States; Recruiting
Kissimmee, Florida, United States; Recruiting
Miami, Florida, United States; Recruiting
New Port Richey, Florida, United States; Recruiting
Ocala, Florida, United States; Recruiting
Pembroke Pines, Florida, United States; Recruiting
West Palm Beach, Florida, United States; Recruiting
Hawaii
Honolulu, Hawaii, United States; Recruiting
Illinois
Arlington Heights, Illinois, United States; Recruiting
Chicago, Illinois, United States; Recruiting
Peoria, Illinois, United States; Recruiting
Indiana
Bloomington, Indiana, United States; Recruiting
Evansville, Indiana, United States; Recruiting
Indianapolis, Indiana, United States; Recruiting
Iowa
Waterloo, Iowa, United States; Recruiting
Kansas
Arkansas City, Kansas, United States; Recruiting
Kansas City, Kansas, United States; Recruiting
Overland Park, Kansas, United States; Recruiting
Wichita, Kansas, United States; Recruiting
Kentucky
Louisville, Kentucky, United States; Recruiting
Maine
Auburn, Maine, United States; Recruiting
Michigan
Livonia, Michigan, United States; Recruiting
Minnesota
Edina, Minnesota, United States; Recruiting
Nebraska
Omaha, Nebraska, United States; Recruiting
Nevada
Las Vegas, Nevada, United States; Recruiting
New Jersey
Edison, New Jersey, United States; Recruiting
Margate, New Jersey, United States; Recruiting
New York
New Hyde Park, New York, United States; Recruiting
Rochester, New York, United States; Recruiting
Syracuse, New York, United States; Recruiting
North Carolina
Hickory, North Carolina, United States; Recruiting
Raleigh, North Carolina, United States; Recruiting
Statesville, North Carolina, United States; Recruiting
Winston Salem, North Carolina, United States; Recruiting
Ohio
Cincinnati, Ohio, United States; Recruiting
Oklahoma
Tulsa, Oklahoma, United States; Recruiting
Oregon
Medford, Oregon, United States; Recruiting
Portland, Oregon, United States; Recruiting
Pennsylvania
Allentown, Pennsylvania, United States; Recruiting
Altoona, Pennsylvania, United States; Recruiting
Downingtown, Pennsylvania, United States; Recruiting
Sellerville, Pennsylvania, United States; Recruiting
Tipton, Pennsylvania, United States; Recruiting
Rhode Island
Warwick, Rhode Island, United States; Recruiting
South Carolina
Charleston, South Carolina, United States; Recruiting
Mt. Pleasant, South Carolina, United States; Recruiting
Simpsonville, South Carolina, United States; Recruiting
Tennessee
Chattanooga, Tennessee, United States; Recruiting
Morristown, Tennessee, United States; Recruiting
Texas
Corpus Christi, Texas, United States; Recruiting
Dallas, Texas, United States; Recruiting
Euless, Texas, United States; Recruiting
San Antonio, Texas, United States; Recruiting
The Colony, Texas, United States; Recruiting
Utah
Ogden, Utah, United States; Recruiting
Salt Lake City, Utah, United States; Recruiting
Virginia
Norfolk, Virginia, United States; Recruiting
Richmond, Virginia, United States; Recruiting
Washington
Renton, Washington, United States; Recruiting
Wisconsin
Madison, Wisconsin, United States; Recruiting
More Information
Last Updated: September 1, 2005
Record first received: August 31, 2005
ClinicalTrials.gov Identifier: NCT00143676
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-06

Not Signed In -


